Royalty Pharma Agrees to Acquire Royalty Interest in
Olpasiran is an siRNA therapeutic being developed by Amgen to reduce risk of cardiovascular disease Arrowhead retains rights to $400 million in...
Source: globenewswire.com
Page 42 - Brian Ritchie News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Brian Ritchie. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Brian Ritchie Today - Breaking & Trending Today
Gerry Wedd's ceramics brought to life in immersive installation WAVE
Premiering as part of the 2022 Adelaide Film Festival, a genre-defying work of art that unites digital imagery, ceramics and sound opened at the a hr
Source: artdaily.com
East of Scotland League: Crossgates Primrose three unbeaten
It's been a busy week of action for West Fife clubs.
Source: dunfermlinepress.com
Sofwave Gains Approval to Market the SUPERB™ Non-Invasive Wrinkle Reduction Device in Brazil
- Brazil’s Health Regulatory Agency, “Agência Nacional de Vigilância Sanitária” (ANVISA) Grants Sofwave Regulatory Approval to Market SUPERB Sofwave Medical Ltd
Source: einnews.com
Sofwave Gains Approval to Market the SUPERB Non-Invasive Wrinkle Reduction Device in Brazil
02.11.2022 - - Brazil’s Health Regulatory Agency, “Agência Nacional de Vigilância Sanitária” (ANVISA) Grants Sofwave Regulatory Approval to Market SUPERB SAN CLEMENTE, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) - Sofwave Medical Ltd (“the Company”) (TASE: SOFW), ...
Source: wallstreet-online.de